Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 8, 2026

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix
10:23

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix

Published on: May 3, 2024

Recombinant self-assembling peptides as biomaterials for tissue engineering.

Stuart Kyle1, Amalia Aggeli, Eileen Ingham

  • 1Institute of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, LS2 9JT, UK.

Biomaterials
|October 12, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ozone as a Next-Generation Sterilization Process in Tissue Engineering and Regenerative Medicine: Critically Bridging Product Stability, Safety and Clinical Translation.

Molecules (Basel, Switzerland)·2026
Same author

Nanotechnology-based strategies for ROS-mediated anticancer and antimicrobial therapies.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Contact-Dependent Antibacterial Performance of Silver Nanoparticles Encapsulated in Collagen-Based Gels.

Journal of functional biomaterials·2026
Same author

The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established cs DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriateness Method consensus study.

Rheumatology (Oxford, England)·2026
Same author

The Ramp to Nowhere: When hope slips through the cracks in care.

The Lancet. Respiratory medicine·2025
Same author

The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs.

Rheumatology (Oxford, England)·2025
Same journal

Oral colon-targeted micro-nano formulation engineered in microfluid for synergistic therapy of inflammatory bowel disease.

Biomaterials·2026
Same journal

Manganese@Gold cluster-coordinated covalent organic frameworks-based artificial metalloenzymes with cascade biocatalysis and amplified systemic stimulation to combat malignant tumor metastasis.

Biomaterials·2026
Same journal

Remodeling TME via feedback-driven photothermal-ferroptosis-immune cascade.

Biomaterials·2026
Same journal

Corrigendum to "Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib" [Biomaterials 2020, 240, 119845].

Biomaterials·2026
Same journal

Mg-integrated octopus-inspired hydrogel dressing enables autonomous adhesion and wound closure for enhanced healing via sequential microenvironment regulation.

Biomaterials·2026
Same journal

Engineering miRNA-223 nanocomplexes via bioorthogonal self-assembly for precision therapy of intervertebral disc degeneration.

Biomaterials·2026
See all related articles

Researchers developed a cost-effective method to produce recombinant self-assembling peptides for tissue engineering. This peptide forms hydrogels with properties similar to chemically synthesized versions, showing great potential for tissue scaffolds.

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Nanotechnology

Background:

  • Self-assembling peptides mimic natural extracellular matrix for tissue engineering.
  • P₁₁-4 peptide self-assembles into a hydrogel under physiological conditions.
  • Recombinant production offers a scalable alternative to chemical synthesis.

Purpose of the Study:

  • To establish a system for producing recombinant P₁₁-4 peptide and related P₁₁-family peptides.
  • To develop an efficient purification strategy for these self-assembling peptides.
  • To evaluate the properties and cytocompatibility of the recombinant peptide hydrogel.

Main Methods:

  • Site-directed mutagenesis to generate peptide expression vectors.
  • Chemical cleavage with cyanogen bromide for purification.

More Related Videos

Preparation of Mechanically Stable Self-Assembled Peptides Hydrogels
05:24

Preparation of Mechanically Stable Self-Assembled Peptides Hydrogels

Published on: September 6, 2024

Culturing Mammalian Cells in Three-dimensional Peptide Scaffolds
07:52

Culturing Mammalian Cells in Three-dimensional Peptide Scaffolds

Published on: June 13, 2018

Related Experiment Videos

Last Updated: Jun 8, 2026

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix
10:23

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix

Published on: May 3, 2024

Preparation of Mechanically Stable Self-Assembled Peptides Hydrogels
05:24

Preparation of Mechanically Stable Self-Assembled Peptides Hydrogels

Published on: September 6, 2024

Culturing Mammalian Cells in Three-dimensional Peptide Scaffolds
07:52

Culturing Mammalian Cells in Three-dimensional Peptide Scaffolds

Published on: June 13, 2018

  • Filtration, lyophilisation, and washing steps for isolation.
  • Physico-chemical characterization and cytocompatibility assays with human dermal fibroblasts.

    • Main Results:

    • Achieved high yields of peptide-fusion protein (ca. 4.64 g/L).
    • Reported high recovery of pure recombinant P₁₁-4 (203 mg/L).
    • Recombinant P₁₁-4 hydrogel exhibited identical properties to chemically synthesized peptide.
    • Demonstrated excellent cytocompatibility with primary human dermal fibroblasts.

    Conclusions:

    • A simple and efficient process for purifying recombinant self-assembling peptides was developed.
    • High levels of recombinant P₁₁-4 can be produced for tissue engineering applications.
    • Recombinant self-assembling peptides are viable alternatives to chemically synthesized ones for scaffold development.